Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke

Overview of attention for article published in New England Journal of Medicine, February 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 7 news outlets
blogs: 10 blogs
policy: 4 policy sources
twitter: 99 X users
patent: 3 patents
facebook: 10 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 2 Google+ users
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 10 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 1160 Mendeley
citeulike: 4 CiteULike

So far, Altmetric has seen 12 public wall posts from 10 users.

Marco Antonio Canedo, 28 Nov 2014

The trial showed similar safety outcomes and no significant difference in functional independence with endovascular therapy…

Radiologická společnost ČLS JEP, 16 Jun 2013

předčasně zrušeno pro marnost průběžných výsledků:-)

Cardio Vascular, 07 Mar 2013

Intravenous tissue plasminogen activator (t-PA; alteplase [Activase, Genentech, or Actilyse, Boehringer Ingelheim]) is the only…

Arab Doctors الاطباء العرب, 06 Mar 2013

Intravenous tissue plasminogen activator (t-PA; alteplase [Activase, Genentech, or Actilyse, Boehringer Ingelheim]) is the only…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 8 additional Facebook posts.